Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4

Cited by (329)

Items 201–300 of 329

1. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1
   Geeske Genrich, Marcus Kruppa, Lennart Lenk, Ole Helm, Anna Broich, Sandra Freitag‐Wolf, Christoph Röcken, Bence Sipos, H. Schäfer, Susanne Sebens · 2016 · BMC Cancer
2. Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer
   Lily Nguyen, Sophie Dobiasch, Günter Schneider, Roland Michael Schmid, Omid Azimzadeh, Kristiyan Kanev, Dominik Buschmann, Michael Walter Pfaffl, Stefan H. Bartzsch, Thomas Ernst Schmid et al. · 2021 · Radiotherapy and Oncology
3. Motility Analysis of Pancreatic Adenocarcinoma Cells Reveals a Role for the Atypical ζ Isoform of Protein Kinase C in Cancer Cell Movement
   Carlo Laudanna, Claudio Sorio, Cristina Tecchio, Eugene C. Butcher, Antonio Bonora, Claudio Bassi, Aldo Scarpa · 2003 · Laboratory Investigation
4. Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan
   Hannah Otterbein, Hendrik Lehnert, Hendrik Ungefroren · 2019 · Cancers
5. Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells
   Andrea Galbiati, Stefania Bova, Raffaella Pacchiana, Chiara Borsari, Marco Persico, Aureliano Zana, Stefano Bruno, Massimo Donadelli, Caterina Fattorusso, Paola Conti · 2023 · European Journal of Medicinal Chemistry
6. Immunohistology of the Pancreas, Biliary Tract, and Liver
   Olca Baştürk, Alton B. Farris, Volkan N. Adsay · 2010 · Elsevier eBooks
7. Mutational Profiling of Kinases in Human Tumours of Pancreatic Origin Identifies Candidate Cancer Genes in Ductal and Ampulla of Vater Carcinomas
   Vincenzo Corbo, Rossana Ritelli, Stefano Barbi, Niccola Funel, Daniela Campani, Alberto Bardelli, Aldo Scarpa · 2010 · PLoS ONE
8. Taraxacum officinale dandelion extracts efficiently inhibited the breast cancer stem cell proliferation
   Van Ngu Trinh, Nghi Doan-Phuong Dang, Diem Hong Tran, Phuc Van Pham · 2016 · Biomedical Research and Therapy
9. Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216
   Beatrice Mohelníková-Duchoňová, Matěj Kočík, B. Mohelníkova Duchonova, Veronika Brynychová, Martin Oliverius, Jan Hlavsa, Eva Honsová, Jan Mazanec, Zdeněk Kala, Iwao Ojima et al. · 2016 · The Pharmacogenomics Journal
10. RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones
    Marco Della Peruta, Cinzia Giagulli, Carlo Laudanna, Aldo Scarpa, Claudio Sorio · 2010 · Molecular Cancer
11. Retrovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transfer in Pancreatic Cancer Cell Lines: An Incomplete Antitumor Effect
    Eliana Greco, Paola Fogar, Daniela Basso, Anna Lisa Stefani, Filippo Navaglia, Carlo‐Federico Zambon, Saverio Mazza, Nicoletta Gallo, Maria Grazia Piva, Aldo Scarpa et al. · 2002 · Pancreas
12. Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Anette Heller, Assia L. Angelova, Sonja Bauer, Svitlana P. Grekova, Marc Aprahamian, Jean Rommelaere, Michael Volkmar, Johannes W.G. Janssen, Nathalie Bauer, Ingrid Herr et al. · 2016 · Pancreas
13. Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer
    Suguru Mitsufuji, Yoshifumi Iwagami, Shogo Kobayashi, Kazuki Sasaki, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Kunihito Gotoh et al. · 2022 · Annals of Surgical Oncology
14. Inhibition of Ankyrin-B Expression Reduces Growth and Invasion of Human Pancreatic Ductal Adenocarcinoma
    Ying Chen, Matthias J. Löhr, Ralf Jesnowski · 2010 · Pancreatology
15. Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo.
    Emily Sherene Van Laar, Stephanie Roth, Steven D. Weitman, John R. MacDonald, Stephen J. Waters · 2004 · PubMed
16. Distribution of breakpoints on chromosome 18 in breast, colorectal, and pancreatic carcinoma cell lines
    Amber E. Alsop, Andrew Erich Teschendorff, Paul A. Edwards · 2006 · Cancer Genetics and Cytogenetics
17. Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells
    Andrew J. Scott, Amanda S. Wilkinson, John C. Wilkinson · 2016 · BMC Cancer
18. Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance
    Ya-Jing Zhang, Chenlei Wen, Yuxin Qin, Xiao-Mei Tang, Min-Min Shi, Boyong Shen, Yuan Fang · 2017 · Oncology Reports
19. Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells
    Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Ming-hua Zhu, Jiaxin Liang, Xiaoran Qin et al. · 2012 · FEBS Journal
20. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis
    Stefania Beghelli, Simonetta Orlandini, Patrick S. Moore, Giorgio Talamini, Paola Capelli, Giuseppe Zamboni, Massimo Falconi, Aldo Scarpa · 2002 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
21. S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells
    Shingo Kozono, Kenoki Ohuchida, Takao Ohtsuka, Lin Cui, Daiki Eguchi, Kenji Fujiwara, Ming Zhao, Kazuhiro Mizumoto, Masao Tanaka · 2013 · Oncology Reports
22. Unraveling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry
    Simon Lagies, Manuel Schlimpert, Lukas M. Braun, Michel Kather, Johannes Plagge, Thalia Erbes, Uwe A. Wittel, Bernd Kammerer · 2019 · Analytical and Bioanalytical Chemistry
23. Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
    Silje Beckinger, Tina Daunke, Leon Aldag, Sandra Krüger, Steffen Markus Heckl, Daniela Wesch, H. Schäfer, Christoph Röcken, Sascha Rahn, Susanne Sebens · 2023 · Frontiers in Oncology
24. Calcium ion delivery by microbubble-assisted sonoporation stimulates cell death in human gastrointestinal cancer cells
    Dawid Przystupski, Dagmara Baczyńska, Joanna Rossowska, Julita Kulbacka, Marek Ussowicz · 2024 · Biomedicine & Pharmacotherapy
25. Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines
    Barbara Chifenti, Mariangela Morelli, Michele Zavaglia, Domenico Antonio Coviello, Silvana Guerneri, Annalisa Santucci, Alessandro Paffetti, M. Masetti, Maria Teresa Locci, Gloria Bertacca et al. · 2009 · Pancreas
26. Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer
    Juraj Hlavatý, Helga Petznek, Harry Holzmüller, Angelika Url, Gerrit Jandl, André Berger, Brian Salmons, Walter H. Günzburg, Matthias Renner · 2012 · PLoS ONE
27. TGF-β and p53 Staining in CT-Guided and Endoscopic Ultrasound Fine-Needle Aspirates of Pancreatic Adenocarcinoma
    Dawn M. Sears, Richard A. Erickson, Lubna Sayage‐Rabie, Martha C. Escobar · 2004 · Digestive Diseases and Sciences
28. Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas
    Aldo Scarpa, Simonetta Orlandini, Patrick S. Moore, Nicholas Robert Lemoine, Stefania Beghelli, Antonella Baron, Massimo Falconi, Giuseppe Zamboni · 2001 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
29. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1
    David I. Radke, Hendrik Ungefroren, Ole Helm, Susann Voigt, Gökhan Alp, Hendrik Braun, Sebastian Hübner, Janine Dilchert, Susanne Sebens, Dieter Adam et al. · 2016 · Cellular Signalling
30. Pancreatic Cancer Cell Lines Heterozygous for the SPINK1 p.N34S Haplotype Exhibit Diminished Expression of the Variant Allele
    Éva Kereszturi, Miklós Sahin‐Tóth · 2017 · Pancreas
31. A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
    Isaac P. Horn, D. Marks, Amanda N. Koenig, Tara L. Hogenson, Luciana L. Almada, Lauren Goldstein, Paola A. Romecin Duran, Renzo E Vera, A. Vrabel, G. Cui et al. · 2021 · Journal of Biological Chemistry
32. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration
    Jennifer R. Kosinski, Antonio S. Sechi, Johanna Hain, Sophia Villwock, Stefanie Anh Ha, Maximilian Hauschulz, Michael Rose, Florian Steib, Nadina Ortiz‐Brüchle, Lara Rosaline Heij et al. · 2024 · Molecular Oncology
33. Cytotoxic action of phorbol esters on human pancreatic cancer cells
    JANE A. BOND, Andreas J. Gescher, Richard D. Verschoyle, Nicholas Robert Lemoine, Rachel J. Errington, Marie Wiltshire, Paul J. Smith, David Wynford‐Thomas · 2007 · International Journal of Cancer
34. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma
    Ziba Lotfi, Shiva Najjary, Fariba Lotfi, Mohammad Ali Amini, Amir Baghbanzadeh, Darya Javad Rashid, Elmira Roshani Asl, Behzad Baradaran, Ahad Mokhtarzadeh · 2021 · European Journal of Pharmacology
35. A potential role of calpains in sulfonylureas (SUs) –mediated death of human pancreatic cancer cells (1.2B4)
    Izabela Szymczak-Pajor, Krzysztof Fleszar, Jacek Kasznicki, Patrycja Gralewska, Agnieszka Śliwińska · 2021 · Toxicology in Vitro
36. Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.
    Stephen G. Chun, Hyunsil Park, RAJ KUMAR PANDITA, Nobuo Horikoshi, Tej K. Pandita, David L Schwartz, John S. Yordy · 2015 · Europe PMC (PubMed Central)
37. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
    Benedetta Ferrara, Erica Dugnani, Valeria Sordi, Valentina Pasquale, Silvia Pellegrini, Michele Reni, Gianpaolo Balzano, Lorenzo Piemonti · 2022 · International Journal of Molecular Sciences
38. A novel cell line and xenograft model of ampulla of Vater adenocarcinoma
    Claudio Sorio, Patrick S. Moore, Maria Grazia Ennas, Cristina Tecchio, Antonio Bonora, Silvia Sartoris, Piera Balzarini, Piergiovanni Grigolato, Aldo Scarpa · 2004 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
39. Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer
    Nelson S. Yee, Weiqiang Zhou, Stephen G. Chun, I-Chau Liang, Rosemary K. Yee · 2012 · Biology Open
40. Complete Models of p53 Better Inform the Impact of Hotspot Mutations
    Maria J. Solares, Deborah F. Kelly · 2022 · International Journal of Molecular Sciences
41. Targeting the hedgehog signaling pathway with interacting peptides to Patched-1
    Masafumi Nakamura, Haruo Tanaka, Yousuke Nagayoshi, Hiroshi Nakashima, Kosuke Tsutsumi, Takao Ohtsuka, Shunichi Takahata, Masao Tanaka, Hidechika Okada · 2011 · Journal of Gastroenterology
42. Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction
    Francesco Giovinazzo, Giorgio Malpeli, Sara Zanini, Marco Daniele Parenti, Lorenzo Piemonti, Marco Colombatti, Maria Teresa Valenti, Luca Dalle Carbonare, Aldo Scarpa, James W. Sinnett‐Smith et al. · 2012 · Cellular Signalling
43. Current methods in mouse models of pancreatic cancer.
    P. Mazur, A. Herner, Florian Neff, J. Siveke · 2015 · Methods in molecular biology
44. Pancreatic cancer organoid-screening captures personalized sensitivity and chemoresistance suppression upon cytochrome P450 3A5-targeted inhibition
    Meritxell B. Cutrona, Jing Wu, Ka Yang, Junmin Peng, Taosheng Chen · 2024 · iScience
45. Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background
    Sven Eisold, Eduard Ryschich, Michael Linnebacher, Thomas Giese, Dirk Nauheimer, Anja Wild, Detlef Klaus Bartsch, Markus Wolfgang Büchler, Jan Schmidt · 2004 · Cancer
46. STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines
    Trevor J. Grant, Anita Kuldeep Mehta, Anamika Gupta, Ahmad A.D. Sharif, Kshitij Satnamdas Arora, Vikram Deshpande, David Tsai Ting, Nabeel M. Bardeesy, Neil J. Ganem, Alexander Hergovich et al. · 2017 · Oncotarget
47. FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells
    Shinji Mima, Chihaya Kakinuma, Tamami Higuchi, Kazunori Saeki, Takayuki Yamada, Rena Uematsu, Miki Ishino, 信子 鬼頭, Hiroki Nishikawa, Hidenobu Kuniyoshi et al. · 2018 · Journal of Pharmacology and Experimental Therapeutics
48. Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation
    Antônio Felix da Silva Filho, Lucas B. Tavares, Maíra Galdino da Rocha Pitta, Eduardo Isidoro Carneiro Beltrão, Moacyr Jesus Barreto de Melo Rêgo · 2020 · Biological Chemistry
49. Analysis of apoptosome dysregulation in pancreatic cancer and of its role in chemoresistance
    Marco Corvaro, Claudia Fuoco, Martin Wagner, Francesco Cecconi · 2007 · Cancer Biology & Therapy
50. Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection
    Wei Shen, Guo‐Qing Tao, Dechun Li, Zhu Xing-guo, Xia Bai, Bing Cai · 2008 · World Journal of Gastroenterology
51. Absence of mutations in the transforming growth factor-β inducible early gene 1, TIEG1, in pancreatic cancer
    Davide Antonello, Patrick S. Moore, Giuseppe Zamboni, Massimo Falconi, Aldo Scarpa · 2002 · Cancer Letters
52. A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
    Paula Marie Schmidtlein, Clara Volz, Rüdiger Braun, Isabel Thürling, Olha Lapshyna, Ulrich Friedrich Wellner, Björn Konukiewitz, Hendrik Lehnert, Jens-Uwe Marquardt, Hendrik Ungefroren · 2021 · Cancers
53. 5-epi-Sinuleptolide from Soft Corals of the Genus Sinularia Exerts Cytotoxic Effects on Pancreatic Cancer Cell Lines via the Inhibition of JAK2/STAT3, AKT, and ERK Activity
    Wan-Chi Tsai, Wen–Hung Wang, Bo-Cian Huang, Chiung‐Yao Huang, Jyh‐Horng Sheu · 2021 · Molecules
54. Analogs of Vitamin E Epitomized by α-Tocopheryl Succinate for Pancreatic Cancer Treatment
    Eliana Greco, Daniela Basso, Elisa Fadi, Andrea Padoan, Paola Fogar, Carlo‐Federico Zambon, Filippo Navaglia, Dania Bozzato, Stefania Moz, Sergio Pedrazzoli et al. · 2010 · Pancreas
55. Study of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis
    Sinem Nalbantoğlu, Mones S. Abu-Asab, Ming Tony Tan, Xuemin Zhang, Ling Cai, Hakima Amri · 2016 · OMICS A Journal of Integrative Biology
56. Galectin-3 Expression in Pancreatic Cell Lines Under Distinct Autophagy-Inducing Stimulus
    Antônio Felix da Silva Filho, Lizandra Maia de Sousa, Sílvio Roberto Consonni, Maíra Galdino da Rocha Pitta, Hernandes F. Carvalho, Moacyr Jesus Barreto de Melo Rêgo · 2020 · Microscopy and Microanalysis
57. Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
    Hidemi Rikiishi · 2010 · Cancers
58. Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient mice
    Juergen Tepel, O. Dagvadorj, Matthias Kapischke, Bence Sipos, Alexander Leins, B. Kremer, Holger Kalthoff · 2005 · International Journal of Colorectal Disease
59. SPINK1 variants in young-onset pancreatic cancer
    Tomáš Hucl, Ralf Jesnowski, Roland H. Pfützer, Hans‐Peter Elsässer, Matthias J. Löhr · 2007 · Journal of Gastroenterology
60. The roles of cell surface attachment molecules and coagulation Factor X in adenovirus 5-mediated gene transfer in pancreatic cancer cells
    Salehhuddin Hamdan, Caroline Sophie Verbeke, N Fox, J Booth, Graham Bottley, Hardev Pandha, George Eric Blair · 2011 · Cancer Gene Therapy
61. A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma
    Clayton S. Lewis, Aniruddha Sunil Karve, Kateryna Matiash, Timothy M. Stone, Jingxing Li, Jordon K. Wang, Henri H. Versteeg, Bruce J. Aronow, Syed Ameen Ahmad, Pankaj B. Desai et al. · 2021 · Frontiers in Oncology
62. Testis‐specific hnRNP is expressed in colorectal cancer cells and accelerates cell growth mediating ZDHHC11 mRNA stabilization
    Yuki Murakami, Hiroaki Konishi, Mikihiro Fujiya, Keitaro Takahashi, Katsuyoshi Ando, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Hiroki Tanabe, Toshikatsu Okumura · 2022 · Cancer Medicine
63. Identification of Genomic Alterations Associated with the Aggressiveness of Pancreatic Cancer Using an Ultra-High-Resolution CGH Array
    A. Legoffic, Ezequiel Luis Calvo, Marc A. Barthet, Jean‐Robert Delpéro, Jean Charles Dagorn, Juan Iovanna · 2009 · Pancreatology
64. The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer
    Noreen Otto, Petra M. Schulz, A Scholz, Peter Hauff, Brigitte Schlegelberger, Katharina M Detjen, Bertram J. Wiedenmann · 2011 · British Journal of Cancer
65. Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer
    Benjamin N. Christopher, Lena Golick, Ashton Basar, Leticia Reyes, Reeder M. Robinson, Aaron O. Angerstein, Carsten Krieg, G. Aaron Hobbs, Denis C. Guttridge D, John P. O’Bryan et al. · 2025 · Biomolecules
66. 10.1538/expanim.63.403
    xxxxxxxxxx xxxxxxxxxx · 2014 · EXPERIMENTAL ANIMALS
67. Inhibition of MLK3 Decreases Proliferation and Increases Antiproliferative Activity of Epidermal Growth Factor Receptor (EGFR) Inhibitor in pancreatic cancer cell Lines
    Sreenivasa Rao Chandana, Cheryl Leece, Kathleen A. Gallo, Burra V. Madhukar, Barbara A. Conley · 2010 · Cancer Growth and Metastasis
68. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
    Maria E. Monberg, Heather M. Geiger, Jaewon James Lee, Roshan Sharma, Alexander Semaan, Vincent Bernard, Justin Wong, Fang Wang, Shaoheng Liang, Daniel B. Swartzlander et al. · 2022 · RePEc: Research Papers in Economics
69. p53 and DPC4 alterations in the bile of patients with pancreatic carcinoma
    Desire Pantalone, Elisbetta Pelo, Barbara Minuti, Irene Giotti, Ernesto Mazza, Massimo Falchini, Bruno Neri, Gabriella Nesi, Lucia Roberta Girardi, Raffaele Pulli et al. · 2004 · Journal of Surgical Oncology
70. Proscillaridin A induces mitochondrial damage and autophagy in pancreatic cancer and reduces the stability of SMAD4 in Panc-1 cells
    Jia Hou, Ning Kang, Nannan Liu, Dan Tan, Si Zhang, Jing Liu, Youhua Xie · 2022 · Annals of Translational Medicine
71. One Hour In Vivo-like Phenotypic Screening System for Anti-cancer Drugs Using a High Precision Surface Plasmon Resonance Device
    Junko Johzuka, Toshihiro Ona, Masatoshi Nomura · 2018 · Analytical Sciences
72. KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanes
    Martin Oliverius, Dominika Flasarova, Beatrice Mohelníková-Duchoňová, Marie Ehrlichová, Viktor Hlaváč, Matěj Kočík, Ondřej Strouhal, Pavel Dvořák, Iwao Ojima, Pavel Souček · 2019 · Mutagenesis
73. p53/FBXL20 axis negatively regulates the protein stability of PR55α, a regulatory subunit of PP2A Ser/Thr phosphatase
    Lepakshe S. V. Madduri, Nichole D. Brandquist, Chitra Palanivel, Geoffrey A. Talmon, Michael J. Baine, Sumin Zhou, Charles A. Enke, Keith R. Johnson, Michel M. Ouellette, Ying Yan · 2021 · Neoplasia
74. Application of 3.0 Tesla Magnetic Resonance Imaging for Diagnosis in the Orthotopic Nude Mouse Model of Pancreatic Cancer
    Li Wu, Chen WANG, Xiuzhong Yao, Kai LIU, Yanjun Xu, Haitao ZHANG, Caixia Fu, Xiaolin WANG, Yingyi LI · 2014 · EXPERIMENTAL ANIMALS
75. Acquired 5-Fluorouracil Resistance in Human Pancreatic Carcinoma Cells. A Paradigm for Chemoresistance Mechanisms in Pancreatic Cancer
    Marvin Schober, Ralf Jesenofsky, R. Faissner, Sebastian Krug, Cornelius Weidenauer, Wolfgang Hagmann, Stephan Haas, Rainer Lothar Heuchel, Matthias J. Löhr · 2015 · Università degli Studi di Napoli Federico II
76. Novel Gene Therapy Approaches to Pancreatic Cancer
    Matthew H. G. Katz, Michael Bouvet · 2003 · International Journal of Gastrointestinal Cancer
77. Stable expression of temperature-sensitive p53: A suitable model to study wild-type p53 function in pancreatic carcinoma cells
    Dieter Nuevemann, Matthias Christgen, Hendrik Ungefroren, Holger Kalthoff · 2006 · Oncology Reports
78. Molecular Aberrations in Periampullary Carcinoma
    Mallika Tewari, Jyoti Ranjan Swain, Vinod Kumar Dixit, Hari Shankar Shukla · 2017 · Indian Journal of Surgical Oncology
79. PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation
    Chitra Palanivel, Lepakshe S. V. Madduri, Ashley L. Hein, Christopher B Jenkins, Brendan T Graff, Alison L. Camero, Sumin Zhou, Charles A. Enke, Michel M. Ouellette, Ying Yan · 2024 · Aging
80. Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
    Charmy Twala, Sibusiso Tebogo Malindisa, Chamoné Munnik, Selisha Ann Sooklal, Monde McMillan Ntwasa · 2025 · Biomedicines
81. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells
    Pei Pei, Alessandro Gregori, Cecilia Bergonzini, Mahsoem Ali, Giulia Mantini, Thomas Schmidt, Francesco Finamore, Stephanie M. Fraga Rodrigues, Adam Enver Frampton, Liam Andrew McDonnell et al. · 2023 · International Journal of Radiation Oncology*Biology*Physics
82. A novel experimental model for human mixed acinar–ductal pancreatic cancer
    Bruno Doiron, Ralph A. DeFronzo · 2017 · Carcinogenesis
83. Models of Pancreatic Cancer: Understanding Disease Progression
    Laleh Golkar Melstrom, Paul J. Grippo · 2008 · Springer eBooks
84. SHP2 Inhibition Abrogates MEK inhibitor Resistance in Multiple Cancer Models
    Carmine Fedele, Hao Ran, Brian Diskin, Wei Wei, Jayu Jen, Kiyomi Y. Araki, Diane M. Simeone, George Miller, Benjamin G. Neel, Kwan Ho Tang · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
85. A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreas cancer
    Brooke A. Brown, Paul J. Myers, Sara J. Adair, Jason Robert Pitarresi, Shiv K. Sah‐Teli, Logan A. Campbell, William S. Hart, Michelle C. Barbeau, Kelsey M. Leong, Nicholas M. Seyler et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
86. Pancreatic intra-epithelial neoplasia: current clinicopathological and molecular considerations
    Aleodor A. Andea, Olca Baştürk, Volkan N. Adsay · 2005 · Current Diagnostic Pathology
87. Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research
    Shuaichen Liu, Wang Guangyi · 2018 · Cellular and Molecular Biology
88. Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor
    Nobuyasu Takahashi, Fumiyo Aoyama, Jiro Ohuchida, Naoki Sameshima, Yujiro Asada, Akira Sawaguchi · 2015 · Human Cell
89. Establishment and Characterization of Two Novel Human Pancreatic Carcinoma Cell Lines.
    Katsuhisa Hirano, Tomoyuki Okumura, Yutaka Shimada, Toru Watanabe, Tetsuji Yamaguchi, Takuya Nagata, Kazuhiro Tsukada · 2015 · PubMed
90. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
    Maria E. Monberg, Heather Geiger, Jaewon James Lee, Roshan Sharma, Alexander Semaan, Vincent Bernard, Daniel B. Swartzlander, Bret M. Stephens, Ken Chen, Matthew HG Katz et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
91. Gene Therapy with p14/tBID Induces Selective and Synergistic Apoptosis in Mutant Ras and Mutant p53 Cancer Cells In Vitro and In Vivo
    Robert Lance Fine, Yuehua Mao, Darío García‐Carracedo, Gloria H. Su, Wanglong Qiu, URI HOCHFELD, GWEN L. NICHOLS, Yongliang Li, Richard D. Dinnen, Anthony J. Raffo et al. · 2023 · Biomedicines
92. SIRT6 cooperates with KDM5C to transcriptionally silence MICAL2 and inhibit tumorigenesis in pancreatic cancer
    Shuai Leng, Wenyan Liu, Yu Han, Zhiqiao Dang, Fengquan Zhang, Wenqian Yu · 2026 · Cell Communication and Signaling
93. Analysis of K-ras gene codon 12 mutation in pancreatic tissue of patients with pancreatic cancer
    Aleksandra Nikolić, S Knĕzević, M. Krsmanovic, Marjan T. Micev, Momčilo Ristanović, Dragica P. Radojkovic · 2009 · Archives of Biological Sciences
94. Deciphering of SOX9 Functions in Pancreatic Cancer Cells
    К. Н. Кашкин, Liya G. Kondratyeva, E. P. Kopantzev, Ivan S. Abramov, Lyudmila Zhukova, И. П. Чернов · 2025 · International Journal of Molecular Sciences
95. Molecular mechanisms of resveratrol-induced apoptosis in human pancreatic cancer cells
    Napaporn Kaewdoungdee, Chariya Hahnvajanawong, Benjamart Chitsomboon, Wongwarut Boonyanugomol, Banchob Sripa, Kovit Pattanapanyasat, Anirban Maitra · 2014 · DOAJ (DOAJ: Directory of Open Access Journals)
96. Human platelet lysate as validated replacement for animal serum to assess chemosensitivity_suppl
    Miriam Pons · 2018 · ALTEX
97. Drug Evaluations in Pancreatic Cancer Culture Systems
    Bhargava Mullapudi, Yongzeng Ding, Xianzhong Ding, Paul J. Grippo · 2010 · Springer eBooks
98. The stellate cancer-associated fibroblast in pancreatic ductal adenocarcinoma; its role in chemoresistance
    Natalie Johnson · 2012
99. TGF-β Signaling and Biglycan in Pancreatic Cancer
    Hendrik Ungefroren · 2008 · Humana Press eBooks
100. Advances in Primary Cell Culture of Pancreatic Cancer
     Niccola Funel · 2014 · Elsevier eBooks